Mast Therapeutics (MSTX) Posts Q1 Loss of 6c/Share

Mast Therapeutics (NYSE: MSTX) reported Q1 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Diana Shipping withdraws bid to acquire Genco Shipping
• Reading (RDI) Tops Q2 EPS by 4c